Stryker SYK
NYSE SYK
$332.07 -7.91 (-2.33%)
At close: Aug 20, 2026 · 2:25 PM UTC

Stryker (SYK) Curent Deferred Tax Liability (2009 - 2010)

Stryker (SYK) posted quarterly Curent Deferred Tax Liability of $26.9 million for Q4 2010, up 11.62% year-over-year from $24.1 million in Q4 2009, and up 11.62% on a QoQ basis from $24.1 million in Q4 2009.

Stryker (SYK) Curent Deferred Tax Liability (2009 - 2010) Analysis & Trends

Stryker has reported Curent Deferred Tax Liability for 2 years, with the latest figure at $26.9 million in Q4 2010.

  • Curent Deferred Tax Liability for Q4 2010 came in at $26.9 million, up 11.62% year-over-year; the trailing twelve-month figure through Dec 2010 was $26.9 million (up 11.62% YoY), and the FY2010 annual result was $26.9 million, up 11.62% from the prior year.
  • Curent Deferred Tax Liability rose to $26.9 million in Q4 2010, from $24.1 million in the prior quarter.
  • Over five years, Curent Deferred Tax Liability peaked at $26.9 million in Q4 2010 and troughed at $24.1 million in Q4 2009.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax Liability (Qtr)
1 Abbott Laboratories 199.44 Bn 193.84 Bn 7.27 Bn -
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn -
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn -
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn -
5 Edwards Lifesciences 51.90 Bn 47.65 Bn 1.35 Bn -
6 Dexcom 34.30 Bn 32.36 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn -
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn -
9 Steris 23.05 Bn 22.56 Bn 684.20 Mn -
10 Zimmer Biomet Holdings 19.21 Bn 18.80 Bn 1.54 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2010 26.90 Mn
Dec 31, 2010 26.90 Mn
Dec 31, 2009 24.10 Mn
Dec 31, 2009 24.10 Mn